Internationally Recognized Gynecologic Oncologist Dr. David A. Fishman Joins NewYork-Presbyterian/Queens and Weill Cornell Medicine

Dr. Fishman is a Renowned Expert in Prevention, Risk Assessment and Detection of Early-Stage Cancer

Jun 21, 2016

Queens, NY

Dr. David A. Fishman has joined NewYork-Presbyterian/Queens, serving as cancer center director, vice chair of obstetrics and gynecology, and director of gynecologic oncology. He also is a member of the Weill Cornell Medicine faculty, having been recruited as a professor of clinical obstetrics and gynecology. Dr. Fishman was previously director of gynecological oncology research and a professor of obstetrics, gynecology and reproductive science at Mount Sinai Hospital.

An internationally recognized gynecologic oncologist, Dr. Fishman is known for his innovative research on the regulation of ovarian metastasis. He has also worked to develop new methods for risk assessment and detection of early-stage ovarian cancer, including an innovative way to use ultrasound technologies to diagnose early-stage ovarian cancer.

“Dr. Fishman is a world-renowned expert in his field, and NewYork-Presbyterian/Queens is delighted to have him lead our cancer center,” said Stephen Mills, president of NewYork-Presbyterian/Queens. “Dr. Fishman and his team elevate our gynecologic oncology services to unprecedented levels and expand our reach in Queens.”

“Dr. Fishman is a distinguished leader in women’s health who brings a wealth of expertise to NewYork-Presbyterian/Queens,” said Dr. Frank Chervenak, chairman of the Department of Obstetrics and Gynecology and the Given Foundation Professor of Obstetrics and Gynecology at Weill Cornell Medicine, and obstetrician and gynecologist-in-chief at NewYork-Presbyterian/Weill Cornell Medical Center. “I can think of no one better to lead the cancer center and provide unparalleled care to women with gynecologic cancers.”

Dr. Fishman has established the NewYork-Presbyterian/Queens Cancer Center Risk Assessment and Cancer Prevention Program, which provides comprehensive, high-quality and innovative care to patients whose personal or family history or genetic makeup increases their risk of developing cancer. Board-certified genetic counselors screen patients for genetic mutations; those found at risk for or who ultimately develop cancer are referred to the appropriate oncology specialist for treatment. The center employs a multidisciplinary approach, integrating psychology, nutritional counseling and palliative care to ensure that all aspects of a patient’s health and wellbeing are addressed.

“The future of oncology is prevention,” Dr. Fishman said. “Our goal is to identify and optimize care for patients who are at increased risk for developing cancer, and to intervene before the disease occurs. We are proud of our comprehensive, multidisciplinary team, which is trying to make a difference to improve patient care using all of the cutting-edge technology and expertise available.”

Dr. Fishman established The National Ovarian Cancer Early Detection Program in 1999 as part of the National Cancer Institute’s Early Detection Research Network, with funding from the National Cancer Institute and philanthropic organizations. In addition, he has performed groundbreaking research on the biology of ovarian cancer, as well as the development of biomarkers for the detection of this disease. He has received grants and awards from organizations including the National Institutes of Health, National Cancer Institute, Society of Gynecologic Oncologists, Gynecologic Cancer Foundation, American Cancer Society, Society of Gynecologic Investigation and the Berlex Foundation. He is the only gynecologic oncologist to receive a National Institutes of Health grant for research on ultrasound detection of ovarian masses.

Dr. Fishman received his medical degree from Texas Tech University Health Sciences Center School of Medicine and completed his residency and fellowship in Obstetrics and Gynecology and Gynecologic Oncology at the Yale School of Medicine.

For additional information on the NewYork-Presbyterian/Queens Cancer Center Risk Assessment and Cancer Prevention Program or to schedule an appointment please call 718-670-1731.


NewYork-Presbyterian/Queens, located in Flushing, New York, is a community teaching hospital affiliated with Weill Cornell Medicine that serves Queens and metro New York residents. The 535-bed tertiary care facility provides services in 14 clinical departments and numerous subspecialties, including 15,000 surgeries and 4,000 infant deliveries each year. With its network of affiliated primary and multispecialty care physician practices and community-based health centers, the hospital provides approximately 162,000 ambulatory care visits and 124,000 emergency service visits annually. For more information, visit

Weill Cornell Medicine

Weill Cornell Medicine is committed to excellence in patient care, scientific discovery and the education of future physicians in New York City and around the world. The doctors and scientists of Weill Cornell Medicine—faculty from Weill Cornell Medical College, Weill Cornell Graduate School of Medical Sciences, and Weill Cornell Physician Organization—are engaged in world-class clinical care and cutting-edge research that connect patients to the latest treatment innovations and prevention strategies. Located in the heart of the Upper East Side's scientific corridor, Weill Cornell Medicine's powerful network of collaborators extends to its parent university Cornell University; to Qatar, where an international campus offers a U.S. medical degree; and to programs in Tanzania, Haiti, Brazil, Austria and Turkey. Weill Cornell Medicine faculty provide comprehensive patient care at NewYork-Presbyterian/Weill Cornell Medical Center, NewYork-Presbyterian/Lower Manhattan Hospital and NewYork-Presbyterian/Queens. Weill Cornell Medicine is also affiliated with Houston Methodist. For more information, visit

Media Contact:

  Jenna Bouffard       212-843-9379       [email protected]

  Sarah Smith       646-962-9537       [email protected]